Please check your internet connection and try again.
## Overview
Sompraz HP is a combination product containing **esomeprazole**, **amoxicillin**, and **clarithromycin** used for the eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Primary Indications
* Eradication of *Helicobacter pylori* infection in patients with active duodenal ulcer or gastric ulcer disease.
## Adult Dosing
The typical regimen is **one Sompraz HP capsule orally twice daily for 10 days**. Each capsule contains esomeprazole 20 mg, amoxicillin 500 mg, and clarithromycin 250 mg.
## Pediatric Dosing
Specific pediatric dosing for Sompraz HP is **not established**. Dosing of individual components (esomeprazole, amoxicillin, clarithromycin) should be considered for pediatric patients based on age, weight, and renal/hepatic function, adhering to specific pediatric guidelines.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment for Sompraz HP is provided. For amoxicillin, dose reduction may be necessary in severe renal impairment (CrCl < 30 mL/min). For clarithromycin and esomeprazole, dose adjustments are generally not required in mild to moderate renal impairment.
* **Hepatic Impairment:** No specific dose adjustment for Sompraz HP is provided. For clarithromycin, reduce the dose by half in patients with hepatic impairment and normal renal function. Esomeprazole may require dose reduction in severe hepatic impairment.
## Contraindications
* Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of severe hypersensitivity reactions to penicillins, cephalosporins, or macrolides.
* Concomitant use with cisapride, ergotamine, ergonovine, midazolam, pimozide, or simvastatin due to the clarithromycin component.
* Use in patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use.
* Electrolyte abnormalities, QT prolongation, or ventricular arrhythmias.
## Adverse Effects
Common adverse effects include:
* **Gastrointestinal:** Diarrhea, nausea, abdominal pain, vomiting, taste disturbance, dry mouth.
* **Allergic Reactions:** Rash, urticaria, pruritus.
* **Other:** Headache, candidiasis, dysgeusia.
Serious adverse effects can include severe allergic reactions, *Clostridioides difficile*-associated diarrhea, hepatotoxicity, and QT prolongation.
## Key Drug Interactions
* **Clarithromycin:** Potentiates the effects of cisapride, ergotamine, ergonovine, midazolam, pimozide, and simvastatin. May increase serum concentrations of carbamazepine, cyclosporine, digoxin, theophylline, triazolam, and warfarin.
* **Esomeprazole:** Can decrease the absorption of drugs that require an acidic gastric environment (e.g., ketoconazole, itraconazole, iron salts). May alter the plasma concentrations of other drugs metabolized by CYP enzymes.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may decrease the renal excretion of amoxicillin.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Assess for *Clostridioides difficile*-associated diarrhea.
* Monitor hepatic function, especially with prolonged use or in patients with pre-existing hepatic disease.
* Evaluate for signs of QT prolongation, particularly in at-risk patients.
* Confirm *H. pylori* eradication (e.g., urea breath test, stool antigen test) after treatment completion, typically 4 weeks post-therapy.
## Clinical Pearls
* Administer Sompraz HP at least 1 hour before a meal to optimize esomeprazole absorption.
* Ensure the full 10-day course is completed, even if symptoms improve earlier.
* Educate patients about potential side effects and when to seek medical attention.
* Consider stool testing for *C. difficile* if diarrhea occurs during or after treatment.
***
*This information is intended for healthcare professionals. Always verify current prescribing information and consult relevant clinical guidelines before making treatment decisions.*
